H Jeffrey Wilkins Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

H Jeffrey Wilkins is Chief Medical Officer of Avalo Therapeutics, Inc.. Currently has a direct ownership of 33,373 shares of AVTX, which is worth approximately $372,108. The most recent transaction as insider was on Dec 10, 2021, when has been sold 6,371 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $10,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.4K
0% 3M change
0% 12M change
Total Value Held $372,108

H Jeffrey Wilkins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2021
BUY
Open market or private purchase
$10,002 $1.57 p/Share
6,371 Added 16.03%
33,373 Common Stock
Jun 10 2021
BUY
Open market or private purchase
$2,079 $2.28 p/Share
912 Added 3.27%
27,002 Common Stock
HJW

H Jeffrey Wilkins

Chief Medical Officer
Rockville, MD

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX